Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
German politician urges more face-to-face interaction in digital age - 2Zelensky sees new Russian attack threat from Belarus
- 3Novartis to build manufacturing hub in North Carolina, creating 700 jobs
- 44K televisions for Extreme Film Watching Experience
- 55 Different ways Macintosh is Prepared to Overwhelm Gaming, Even Against Windows
- Instructions to Pick the Right Tires for Your Slam 1500.
- Everyday Seasonal Positions That Compensate Fairly in the US
- Most loved Amusement Park for Small children: Which One Do You Suggest?
- Grasping the Qualifications Among Separation and Dissolution
- The Best Internet based Retailers for Style and Frill
- Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
- Closets for Your Room: Plan and Utility Features
- Most loved Specially prepared Espresso Mix: Which Meal Do You Adore the Most?
- Gaza humanitarian efforts reach key milestone as UNICEF vaccinates some 13,000 children
